1 – 10 of 20
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Macrophage expressed tartrate-resistant acid phosphatase 5 promotes pulmonary fibrosis progression
(
- Contribution to journal › Article
-
Mark
Is a bacterial biofilm in the lacrimal sac the cause of chronic refractory dacryocystitis?–A pilot study
(
- Contribution to journal › Article
-
Mark
The role of extracellular vesicle fusion with target cells in triggering systemic inflammation
(
- Contribution to journal › Article
-
Mark
A novel quinoline with airway relaxant effects and anti-inflammatory properties
(
- Contribution to journal › Article
- 2023
-
Mark
Small-molecule-mediated OGG1 inhibition attenuates pulmonary inflammation and lung fibrosis in a murine lung fibrosis model
(
- Contribution to journal › Article
-
Mark
Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction
(
- Contribution to journal › Article
- 2022
-
Mark
Zoledronic Acid Targeting of the Mevalonate Pathway Causes Reduced Cell Recruitment and Attenuates Pulmonary Fibrosis
(
- Contribution to journal › Article
-
Mark
Pharmacological OGG1 inhibition decreases murine allergic airway inflammation
(
- Contribution to journal › Article
-
Mark
Tartrate resistant acid phosphatase 5 (TRAP5) mediates immune cell recruitment in a murine model of pulmonary bacterial infection
(
- Contribution to journal › Article
- 2021
-
Mark
Citrullination of extracellular histone H3.1 reduces antibacterial activity and exacerbates its proteolytic degradation
(
- Contribution to journal › Article